Skip over main navigation
  • Log in
  • Basket: (0 items)
Solving Kids' Cancer
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
Shop Contact us Donate
Menu
  • About Neuroblastoma
    • About Neuroblastoma Home
    • What is neuroblastoma?
    • Symptoms
    • Diagnosis
    • Risk Groups and Staging
    • Clinical Trials
    • Treatment for Neuroblastoma
  • Find Support
    • Family support
    • Access treatment
    • Neuroblastoma Parent Education Conference
      • Neuroblastoma Parent Global Symposium 2021
      • See past conferences
    • Other sources of help
  • Research
    • Our research
    • Scientific Advisory Board
    • Research Funding
      • Funding award process
      • Grant Award Calls
    • Projects
    • Funding partners
    • Research policies
    • Research blog
  • Get Involved
    • Help Us Today
    • Shop
    • Ambassador Programme
    • Corporate partnerships
    • Challenge events
    • Set up a fundraising page
    • Gaming
    • Fundraising resources
  • Children’s stories
    • Stories
    • Children’s campaigns
    • In memory
    • Named funds
  • About us
    • What we do
    • Meet the team
      • Trustees
      • Our team
    • Patrons
    • Parent Involvement Forum
    • Join our Team
    • Annual reports
  • News
    • News
    • Blogs
  • Admin
    • Log in
  • Basket: (0 items)
  • Landmark Transatlantic Trial for Children with High-Risk Neuroblastoma Funded by Parent-Led Charities

    Landmark Transatlantic Trial for Children with High-Risk Neuroblastoma Funded by Parent-Led Charities

    In a landmark in paediatric oncology research, children with high-risk neuroblastoma across Europe and North America will be treated together for the first time. Read more

  • Grant awarded to open SIOPEN High-Risk Neuroblastoma Clinical Trial 2 across the UK in 2021

    Grant awarded to open SIOPEN High-Risk Neuroblastoma Clinical Trial 2 across the UK in 2021

    Grant Award - High-Risk Neuroblastoma Clinical Trial 2 Read more

  • Landmark Transatlantic Trial for Children with High-Risk Neuroblastoma Funded by Parent-Led Charities
  • Grant awarded to open SIOPEN High-Risk Neuroblastoma Clinical Trial 2 across the UK in 2021
  • Next
  • Prev
  1. Home
  2. Research projects

Research projects

BEACON Immuno (anti-GD2 amendment)

BEACON Immuno (anti-GD2 amendment)

The BEACON study is a chemotherapy and antibody combination trial. Read more

Published: 11th June, 2019

Updated: 19th August, 2019

Author: Deleted User

National Neuroblastoma Genetics Reference Centre

National Neuroblastoma Genetics Reference Centre

The National Neuroblastoma Genetics Reference Centre aims to provide a comprehensive service genetic characterisation of all neuroblastoma tumours at diagnosis and a subset at relapse. Read more

Published: 12th June, 2019

Updated: 20th August, 2019

Author: Deleted User

PTPP – ITCC-P4 Collaboration

PTPP – ITCC-P4 Collaboration

Bringing together American NCI PPTC and European ITCC-P4 paediatric preclinical research consortiums together for the first time ever via the Pediatric Cancer Working Group at the AACR Annual Meeting. Read more

Published: 11th June, 2019

Updated: 20th August, 2019

Author: Deleted User

MiNivAn : Phase I study of I-131 MIBG, nivolumab and ch14.18/CHO

MiNivAn : Phase I study of I-131 MIBG, nivolumab and ch14.18/CHO

MiNivAn aims to improve the cure rate of children with relapsed or refractory neuroblastoma by combining targeted radiotherapy (I-131 MIBG) with the antibodies anti-GD2 (ch14.18/CHO) and anti-PD1 (nivolumab). Read more

Published: 12th June, 2019

Updated: 20th August, 2019

Author: Deleted User

Biomarker evaluation of neuroblastoma mRNAs in children enrolled in the BEACON trial

Biomarker evaluation of neuroblastoma mRNAs in children enrolled in the BEACON trial

In this study, blood and bone marrow samples from 120 children treated in the BEACON-Neuroblastoma trial will be collected in order to analyse levels of neuroblastoma mRNAs Read more

Published: 12th June, 2019

Updated: 20th August, 2019

Author: Deleted User

Lorlatinib (PF-06463922) : Third-generation ALK inhibitor

Lorlatinib (PF-06463922) : Third-generation ALK inhibitor

This exciting new clinical trial sees 17 transatlantic centres in the UK, USA and Europe, recruiting patients simultaneously for an innovative new third-generation ALK-inhibitor agent lorlatinib (PF-06463922). Read more

Published: 3rd September, 2019

Updated: 14th October, 2019

Author: Deleted User

Neuroblastoma Senior Trials Coordinator

Solving Kids’ Cancer funds a dedicated Senior Trials Coordinator for Neuroblastoma within the Children’s Cancer Trials Team (CCTU) of the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham. Read more

Published: 11th June, 2019

Updated: 19th May, 2020

Author: Deleted User

Grant awarded to open SIOPEN High-Risk Neuroblastoma Clinical Trial 2 across the UK in 2021

Grant awarded to open SIOPEN High-Risk Neuroblastoma Clinical Trial 2 across the UK in 2021

Grant Award - High-Risk Neuroblastoma Clinical Trial 2 Read more

Published: 19th May, 2020

Author: Anne Denman

Charities fund new clinical trial

Charities fund new clinical trial

Solving Kids’ Cancer, with Neuroblastoma UK, has awarded a grant of £609,762.40 to enable the SIOPEN High-Risk Neuroblastoma Clinical Trial 2 (HR-NBL2) to open in the UK, it is anticipated to open in early 2021. Read more

Published: 19th May, 2020

Updated: 2nd December, 2020

Author: Anne Denman

Grant awarded to identify markers of poor survival in high-risk neuroblastoma

Grant awarded to identify markers of poor survival in high-risk neuroblastoma

Solving Kids’ Cancer Europe, Solving Kids' Cancer in New York, Oscar Knox Fund and Merryn Lacy Trust have awarded a grant of $420,000 to co-investigators. Read more

Published: 18th November, 2019

Updated: 7th December, 2020

Author: Deleted User

Grant awarded to identify markers of poor survival in high-risk neuroblastoma

Grant awarded to identify markers of poor survival in high-risk neuroblastoma

Solving Kids’ Cancer Europe, Solving Kids' Cancer in New York, Oscar Knox Fund and Merryn Lacy Trust have awarded a grant of $420,000 to co-investigators. Read more

Published: 18th November, 2019

Updated: 7th December, 2020

Author: Anne Denman

Landmark Transatlantic Trial for Children with High-Risk Neuroblastoma Funded by Parent-Led Charities

Landmark Transatlantic Trial for Children with High-Risk Neuroblastoma Funded by Parent-Led Charities

In a landmark in paediatric oncology research, children with high-risk neuroblastoma across Europe and North America will be treated together for the first time. Read more

Published: 6th November, 2020

Updated: 10th December, 2020

Author: Anne Denman

Grant Awarded for Research into Identifying and Treating Chemotherapy-Resistant Neuroblastoma

Grant Awarded for Research into Identifying and Treating Chemotherapy-Resistant Neuroblastoma

Solving Kids’ Cancer UK with partners; Solving Kids’ Cancer in New York, Joining Against Cancer in Kids (J-A-C-K), ZOE4LIFE, Merryn Lacy Trust and the Oscar Knox Fund have awarded £500,000 to the Children’s Hospital of Philadelphia (CHOP) and collaborating institutions for research into identifying and treating neuroblastoma in newly diagnosed children that is resistant to current standard chemotherapy. Read more

Published: 16th April, 2021

Updated: 29th April, 2021

Author: Emily Hall

International Neuroblastoma Research Initiative 2018

International Neuroblastoma Research Initiative 2018

Solving Kids’ Cancer is leading an international competitive funding call commencing with a Request for Applications (RFA) Read more

Published: 11th June, 2019

Updated: 18th November, 2021

Author: Deleted User

International Research Initiative 2019

International Research Initiative 2019

Solving Kids’ Cancer has issued a joint 2019 International Challenge Grant Call for GBP 500,000 awarded over three years Read more

Published: 14th October, 2018

Updated: 18th November, 2021

Author: Deleted User

Back to top

Showing 10 of 15

Latest

  • Ronin's Spidey Hike

    Ronin's Spidey Hike

    Ronin is doing a 3 mile hike home from playgroup on the last day of term to raise money for his cousin Flora. He will be dressed up as Spiderman!
    Ronin loves walking and would like to help raise lots of money for Floras treatment in America

    Thankyou so much for any donations

  • Family Support Coordinator

    Solving Kids' Cancer is looking for a Family Support Coordinator to join the Family Support Service

  • Judes birthday fundraiser

    Judes birthday fundraiser

    To help Jude get to America to get the next step of his treatment ❤️

  • Rother Valley Sponsored Walk #ForJude

    Rother Valley Sponsored Walk #ForJude

    We are doing a sponsored walk to raise money to get Jude to America for additional cancer treatment

Most read

  • Beau's Campaign

    Beau's Campaign

    Beau was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in December 2020. Her family are appealing for your help to raise £317,000 by May 2022.

  • Flora's Campaign

    Flora's Campaign

    In January 2021 Flora was diagnosed with Autism Spectrum Disorder, and just three months later her parents were given the devastating news she had high-risk neuroblastoma. Her family are appealing for your help to raise £312,000 by August 2022 for Flora to enrol on the Bivalent Vaccine clinical trial in New York that aims to stop her neuroblastoma from coming back.

  • Joseph Yeandle

    Joseph Yeandle

    We are devastated to share the news that beautiful Joseph has sadly passed away.

  • Jude's Campaign

    Jude's Campaign

    Jude is a Dinosaur and animal-loving three-year-old. In July 2021 Jude was diagnosed with high-risk neuroblastoma, a rare and aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.

  • Maysaa's Campaign

    Maysaa's Campaign

    Four-year-old Maysaa was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in March 2021. Her family are asking for your support to raise £106,000 by August 2022 for Maysaa to enrol on the DFMO study in Charlotte that aims to stop her neuroblastoma from coming back.

  • Chloe’s Journey

    Chloe’s Journey

    Beautiful Chloe passed away on the 4th of February 2022.

  • Eden's Campaign

    Eden's Campaign

    Six-year-old Eden was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in April 2021.

  • Peter's Campaign

    Peter's Campaign

    11-year-old Peter was diagnosed with neuroblastoma in early 2019. Devastatingly he relapsed in August 2020 after being clear of disease for 6 months. His family are asking for your support to raise £152,000 so that Peter can complete the DFMO study in Charlotte, North Carolina.

  • Kayla's Campaign

    Kayla's Campaign

    Three-year-old Kayla was diagnosed with high-risk neuroblastoma in May 2021. Kayla’s parents are asking for your help to raise £221,000 by November 2022 for Kayla to enrol on the bivalent vaccine clinical trial in New York that aims to stop her neuroblastoma from coming back.

  • Ollie Sweeney

    Ollie Sweeney

    Ollie's family shared the devastating news that their beautiful boy passed away on Sunday 18th July 2021.

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

Contact us

Solving Kids' Cancer UK
Coram Campus
41 Brunswick Square
London
WC1N 1AZ

Phone: 020 7284 0800

Follow us

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn

  • Jobs
  • Media enquiries
  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Safeguarding Statement
  • Privacy Policy

Solving Kids’ Cancer UK is a registered charity in England and Wales (1135601), and in Scotland (SCO45094). It is a company limited by guarantee in England and Wales (7208648). The charity and company is currently operating as Solving Kids’ Cancer.